Barrs Pharmaceuticals Secures R92m Hetero Investment
Barrs Pharmaceuticals has exited business rescue after agreeing to sell a controlling stake to Hetero. The deal signals a reset for a local manufacturer that has faced both operational disruption and regulatory pressure…. Membership Required You must be a member to access this content.View Membership LevelsAlready a member? Log in here...
HIV Drug Tender Facing Legal Challenge from Hetero SA
Hetero SA challenges the HIV drug tender decision in court, claiming exclusion from vital antiretroviral supply contracts.